Kotak Small Cap Fund Regular-Growth
The fund is rated 0 stars. The balance between returns and downside risk provided limited support. Investment selection within each asset type and investment selection within each industry were the main limitations and did not provide enough support for a higher rating. Above-average fund size of Rs 19,678.75 crore was a minor drawback.
This fund has a bad track record with Asset Selection/Timing, a bad track record with Stock Selection/Timing. It is important to note, however, that this fund has a 19678.753 AUM and a 1.725 expense ratio. Considering all these factors, we have rated this fund as 0.0 star.
Our score weighs long-term performance, risk and consistency — not just past returns.
Returns
As of 8 Oct 2026
Risk ratios
As of 30 Sep 2026
Portfolio
As of 31 Aug 2026
Market-cap split
Sector allocation
Holdings (80)
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| Aster DM Quality Care Ltd. | 4.29% | ₹844.29 Cr | 1,11,67,820 |
| Vijaya Diagnostic Centre Ltd. | 4.21% | ₹828.24 Cr | 54,54,656 |
| Sansera Engineering Ltd. | 4.15% | ₹816.78 Cr | 20,32,796 |
| Krishna Institute of Medical Sciences Ltd | 3.25% | ₹638.71 Cr | 84,54,118 |
| Kalpataru Projects International Ltd. | 2.54% | ₹500.42 Cr | 35,72,133 |
| Minda Corporation Ltd. | 2.39% | ₹470.8 Cr | 66,07,215 |
| Century Plyboards (India) Ltd. | 2.25% | ₹441.99 Cr | 58,36,731 |
| Five-Star Business Finance Ltd. | 2.12% | ₹416.28 Cr | 77,80,174 |
| Shriram Finance Ltd | 2.03% | ₹399.95 Cr | 36,03,518 |
| Ajanta Pharma Ltd. | 1.99% | ₹391.21 Cr | 10,86,134 |
Fund details
Long term capital growth. Investment in equity & equity related securities predominantly in small cap Stocks.
The scheme seeks to generate capital appreciation from a diversified portfolio of equity and equity related securities by investing predominantly in small cap companies.
Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days